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Background: Although hypotheses have been proposed regarding the biological mechanisms of hormo-
nal ﬂuctuations in mood disorders, few epidemiological studies have addressed this issue. The aim of this
study was to examine the association between hormone-related life events and postmenopausal
depression.
Methods: Of 13,918 women who participated in the Korean National Health and Nutrition Examination
Survey (KNHANES) V, a total of 4869 post-menopausal women who had completed information on
depression onset age and additional reproductive factors were included in the analysis. A multivariate
logistic regression was applied to calculate the odds ratios between reproductive factors and post-
menopausal onset depression.
Results: A total of 276 women (5.7%) were diagnosed with depression after menopause. Longer
reproductive years were associated with a reduced risk of depression (for more than 35 reproductive
years: OR¼0.41, 95% CI: 0.27–0.62, P-trendo0.001). Similarly, a later age of menopause (52 years and
older) corresponded to a decreased risk of depression (OR¼0.35, 95% CI: 0.22–0.55) compared to the
women with a menopausal age younger than 46 years. Greater numbers of pregnancies and exogenous
hormone use were also associated with increased risk of depression.
Limitations: All data were collected from interviews using questionnaires. There may be some
inaccuracies in recall of lifetime reproductive events, but women generally recalled their hormonal
events correctly.
Conclusion: Early menopause and the use of exogenous hormones were associated with the risk of post-
menopausal depression. Clinicians should closely monitor and consider further screening for depressed
women who undergo early menopause or those with exogenous hormone use.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Depression is a major health problem worldwide, and it is
expected to be the main contributor to the burden of disease in the
future (Mathers and Loncar, 2006). In the National Comorbidity
Survey (NCS) of the United States, the lifetime prevalence of major
depressive disorder (MDD) was 12.7% for men and 21.3% for
women (Kessler et al., 1993), and more recent data presented a
nearly doubled lifetime risk of MDD in women (OR¼1.7, 95% CI
1.5–2.0) (Kessler et al., 2003). Several studies have interpreted
these phenomena to be related to female-speciﬁc reproductive
events (Cyranowski et al., 2000; Soares and Zitek, 2008). Women
are particularly susceptible to depression at times of hormonal
ﬂuctuations, such as the transitions between the premenstrual,
postnatal and peri-menopausal phases (Bromberger et al., 2010;
Burt and Stein, 2002; Gibbs et al., 2012). Several articles have been
published based on the assumption that ﬂuctuations in sex
hormones in female reproductive events can affect neurochemical
pathways related to depression (Bloch et al., 2000; Noble, 2005;
Soares and Zitek, 2008).
A series of studies support the idea that there is an increased
risk of depression related to reproductive life events in women
who are more sensitive to hormonal changes (Bloch et al., 2000;
Halbreich, 2003). Women's particular susceptibility to mood
disorders during stages of hormone changes is explained by the
neuro-modulating effect of estrogen within interactions with
serotonergic system (Amin et al., 2005). Hormonal changes in
Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/jad
Journal of Affective Disorders
http://dx.doi.org/10.1016/j.jad.2014.12.061
0165-0327/& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
n Correspondence to: Department of Preventive Medicine Seoul National
University College of Medicine 103 Daehak-ro, Jongno-gu, Seoul 110-799,
Republic of Korea. Tel.: þ82 2 740 8326; fax: þ82 2 747 4830.
E-mail address: dhkang@snu.ac.kr (D. Kang).
Journal of Affective Disorders 175 (2015) 176–183
reproductive events contribute to the dysregulation of the seroto-
nergic and noradrenergic systems involved in mood and behavior
(Cohen et al., 2006b; Deecher et al., 2008). It has been hypothe-
sized that a reduced capacity to adapt to ﬂuctuations of estradiol
or progesterone may predispose certain women to depression
(Deecher et al., 2008).
However, the relationship between hormonal events and
depressive illness in women remains controversial. A French study
showed that early menopause was associated with a higher risk of
late-life depression (Ryan et al., 2008), and a study from the U.S.
demonstrated that women with more children had a lower risk of
depression (Harlow et al., 1999). Furthermore, although pregnancy
is believed to be protective against psychiatric disorders, there is
accumulating evidence that supports the opposite conclusion
(Cohen et al., 2006a). However, there is not enough evidence to
prove the effects of natural reproductive hormones on developing
depression, and few epidemiological studies have been conducted
on this issue, especially in Asian women. For exogenous hormones,
a meta-analysis analyzed 26 studies and summarized that hor-
mone replacement therapies (HRTs) have beneﬁcial effects in
reducing depressed mood among postmenopausal women
(Zweifel and O’Brien, 1997). Still, a subsequent study argued that
these studies had predominantly poor methodological quality
(Stoppe and Doren, 2002).
Menopause is a particularly inﬂuential period during which
women have to adapt to a new biological transition. Women with
postmenopausal depression tend to have lower estradiol and
serotonin concentrations, in contrast to high levels of follicle
stimulating hormone (Jasienska et al., 2005). These hormones
are able to alter the functions of the nervous system (Jasienska
et al., 2005). Additionally, many publications have reported on the
protective effects of hormone replacement therapy on depressive
symptoms (Hlatky et al., 2002; Kugaya et al., 2003; Morrison et al.,
2004; Schmidt et al., 2000; Soares et al., 2001; Wihlback et al.,
2001), and many studies have focused on the hormonal treatment
of postmenopausal depression. Even if the protective effects of
estrogen towards neuronal systems were proven by experimental
studies, the protective effects of hormone replacement therapy in
women who undergo menopause remain controversial (Ancelin
et al., 2007). Additionally, because many studies on the effects of
hormone replacement therapy and depression have primarily
consisted of Western populations, evidence among Asian women
is minimal.
The objectives of this study were to estimate the association
between reproductive factors and the onset of postmenopausal
depression in the Korean population and to further elucidate the role
of hormone-related factors on post-menopausal onset depression.
2. Materials and methods
2.1. Study participants
The data used in this study were derived from the Korean
National Health and Nutritional Examination Survey (KNHANES) V
(2010–2012). Based on the National Health Promotion Act
announced in 1995, KNHANES began in 1998. Samples were
recruited using a multi-stage clustered probability design. From
approximately 200,000 primary sampling units (PSU) deﬁned by
geographical regions in the entire country, the ﬁnal PSU for the
actual survey were extracted. The survey used data of approxi-
mately 10,000 individuals each year between 2010 and 2012. The
sample weights were used to calculate all statistics of this survey.
To represent the Korean population with sample participants,
sample weights were created, considering survey non-response,
complex survey design and post-stratiﬁcation. KNHANES is a
series of nationwide cross-sectional studies that targeted a nation-
ally representative population who are non-institutionalized resi-
dents in Korea. Trained interviewers conducted all the interviews
using structured questionnaires to obtain information including
sociodemographic factors, health-related factors, lifestyle factors,
the use of medical services and female reproductive factors.
Further information about KNHANES can be found elsewhere
(Kweon et al., 2014). A total of 13,913 women participated in the
KNHANES V (2010–2012) survey. The analysis in this study was
conﬁned to a total of 4869 respondents over 19 years old who had
gone through menopause and had no missing values for the
reproductive factors and outcome variables (Fig. 1). Only those
who had a ﬁrst depression diagnosis after menopause were
considered, and those who had a depression diagnosis before
menopause were excluded from the analysis.
2.2. Measures
The presence of depression was determined by the question,
“Have you ever been diagnosed with depression conﬁrmed by a
physician?”; those who provided information regarding their age
at ﬁrst diagnosis were included in the analysis. The endogenous
hormone-related factors included menarche and menopause age,
total reproductive years, number of pregnancies, ﬁrst birth age and
breastfeeding duration. The number of pregnancies was classiﬁed
as total pregnancies including abortions and pregnancy without
any abortion. The number of abortions were classiﬁed as the
total number of abortions, including spontaneous and artiﬁcial
Total women in 5th
KNHANES
N=13,918
Women age ≥ 19 years in 5th
KNHANES
N=11,138
Menopaused women 
N=5,188
Women with out missing 
data on menopause and 
depression diagnosis age
N= 5,134
Women age <19 years in 5th
KNHANES
N=2,780
Not menopaused(5102) or 
menopausal status 
unknown(848)
N= 5,950
Women with missing data 
on menopause age(46) or 
depression diagnosis age(8)
N= 54
Women who have earlier 
depression diagnosis age 
than menopausal age 
N= 117
Women with depression 
onset later than menopause
N=5,017 Women with missing data 
on other reproductive 
factors
N=1 48
Final women for analysis
N=4,869
Fig. 1. Selection of participants for analysis.
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abortions, number of spontaneous abortions only and number of
artiﬁcial abortions only. The total number of reproductive years
was calculated based on the menarche age and menopause age.
The exogenous hormone-related factors included oral contracep-
tive (OC) usage duration and HRT starting age and duration.
Information on age, household income, educational level,
marital status, occupation, number of family members, number
of generations living together, education of both parents, other
comorbid diseases and the Alcohol Use Disorders Identiﬁcation
Test (AUDIT) score (Barbor et al., 2001) was obtained to provide a
sociodemographic background and the medical conditions of the
participants. Age was classiﬁed into four groups by quartile (r56
years, 57–63 years, 64–71 years or 471 years). Education was
classiﬁed by attainment years (r6 years, 7–9 years, 10–12, and
412 years). Marital status was classiﬁed into three groups: never
married, married and living with a spouse or married but living
alone due to divorce or the death of a spouse. Comorbid diseases
were: coronary heart disease, stroke, diabetes mellitus, chronic
renal failure, cancers of stomach, liver, colorectum, breast, uterine
cervix, lung and thyroid and chronic hepatitis B or C virus
infection.
2.3. Statistical analysis
Because KNHANES represents the total population of South
Korea, population weights were used. By applying the PROC
SURVEY in SAS version 9.3 (SAS Institute Inc., Cary, NC, USA), the
distributions of the cluster sample, covariance and signiﬁcance
were corrected. The percentages of participants were calculated
based on the sociodemographic characteristics to provide descrip-
tions of the data. Generally, participants were excluded from the
study if they had any missing values in the diagnosis of depression
or age of depression diagnosis. Similarly, if women had no value on
each reproductive factor, such as menarche age, menopause age,
menopause status, type of menopause, ﬁrst pregnancy age, preg-
nancy number among ever pregnant women, ﬁrst birth age, last
birth age, breast feeding duration among ever parous women, OC
usage duration among OC users and HRT usage duration among
HRT users, they were excluded from the analysis. For covariates in
the model, missing values were coded separately to be applied in
the ﬁnal model. The stepwise likelihood ratio test was conducted
and the ﬁnal model included age, occupational status, marital
status, comorbidity and AUDIT score for adjustment variables.
Variables for hormonal events were categorized as followed:
menarche age (r14, 15–16, 17, Z18 years old), menopause age
(o46, 46–49, 50–51, Z52 years old), ﬁrst birth age (r21, 22–23,
24–25, Z26 years old), last birth age (r27, 28–30, 31–33, Z34
years old), OC usage duration (never, 10, 11–22, Z23 months) and
HRT duration (never, r7, 8–35, Z36 months). The adjusted odds
ratios (ORs) and 95% conﬁdence intervals (CIs) were calculated
using a multivariate logistic regression analysis to evaluate the
associations between endogenous hormonal factors, exogenous
hormonal factors and depression onset, with adjustments made
for the covariates. All statistical analyses were performed using
SAS version 9.3 (SAS Institute Inc., Cary, NC, USA), and the level of
signiﬁcance was Po0.05.
2.4. Ethics
All participants agreed to provide written consent to partici-
pate in KNHANES. The Institutional Review Board of the Seoul
National University Hospital in Seoul, Korea, approved the use of
publicly available data for statistical analysis. (IRB no. 1406-058-
586)
3. Results
3.1. Baseline characteristics of the study population
A total of 276 participants (weighted percentage 5.1%) were
diagnosed with depression after menopause. The mean age in the
depression group was 64.4 years, and the mean age in the non-
depression group was 63.9 years. As shown in Table 1, there was a
Table 1
Characteristics of post-menopausal women who ever had menstruation stratiﬁed
by depression using the Korea NHANES 2010–2012 (weighted).
Variables (n¼4869, weighted N¼7,065,898) P-value
Never diagnosed
depression
Post-mentsrual
onset depression
(n¼4593, 94.3%) (n¼276, 5.7%)
(weighted
N¼6,704,673, 94.9%)
(weighted
N¼361,225, 5.1%)
General factors Weighted %a Weighted %a
Age (Years) 0.118
r56 33.2 32.2
57–63 23.4 22.8
64–71 20.6 27.4
471 22.7 17.5
Family income percentileb 0.219
o25% 25.7 31.3
25–50% 26.4 22.5
51–75% 25.1 27.6
475% 22.8 18.6
Education
attainment
years
0.051
r6 58.3 61.6
7–9 16.9 11.7
10–12 18.4 23.3
412 6.4 3.4
Marital status 0.204
Never married 0.8 0.1
Married–living
together
67.9 71.5
Married–others 31.3 28.4
Occupation 0.373
Wage working 21.8 17.5
Self-supporting 12 12.2
House-employed 10.7 7.8
No ﬁnancial
activity
55.5 62.5
Number of family
members
0.753
Living alone 12.9 12.4
Living with one
family member
36.9 39.7
Living with more
than one
member
50.2 47.9
AUDITc score 0.061
0–7 62.8 62.0
8–19 5.3 4.8
20–40 0.5 2.2
Number of comorbid
disease
0.100
0 76.9 70.9
1 19.6 23.2
Z2 3.4 6.0
Number of diseases was counted among coronary heart disease, stroke, diabetes
mellitus, chronic renal failure, solid cancers (gastric, liver, colon, breast, cervix, lung
and thyroid) and hepatitis virus (HBV and HCV) infection.
a Sum of numbers can miss the total number in group due to missing values.
b Each income amount in quartile is different by age strata.
c The Alcohol Use Disorders Identiﬁcation Test.
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smaller proportion of participants who had at least some college
education in the depression group (3.4%) compared to the non-
depression group (6.4%), and a larger percentage of those who had
less than an elementary school education were in the depression
group (61.6%) than in the non-depression group (58.3%). Similarly,
the percentage of women without a regular job by which to
participate in ﬁnancial activity was larger in the depression group
(62.5%) than in the non-depressed group (55.5%). The distribution
of number of comorbid diseases and AUDIT score were presented
in the Table 1. As shown in Table 1, no statistically signiﬁcant
differences were observed between the groups based on family
income quartile, marital status or number of family members.
Likewise, there were no signiﬁcant differences in the number of
generations living together and the education level of both parents
after adjusting for age (data not shown).
3.2. Endogenous hormone-related factors
In the multivariate analysis (Table 2), there was a statistically
signiﬁcant trend relating the total number of reproductive years to
post-menopausal onset depression (P-trend o0.001). As the
period of reproductive years increased, the odds ratio of depres-
sion decreased. Women with a total number of reproductive years
greater than 35 had an OR of 0.41 (95% CI: 0.27–0.62) compared to
those with less than 30 reproductive years after adjusted for age.
The age at menarche showed no signiﬁcant trend in post-
menopausal onset depression. However, compared to those who
experienced menopause before 46 years old, women who under-
went menopause at 52 years old or later had an OR of 0.35 (95% CI:
0.22–0.55).
Compared to the women who had no pregnancies or at least
3 pregnancies, including abortions, women who had 7 or more
pregnancies had a 1.3-fold increased risk of depression onset (95%
CI: 0.84–2.04). If limited to pregnancies without abortion, no
group showed signiﬁcant results in OR. Compared to those who
had no abortion during their pregnancies, women who underwent
abortion more than 3 times showed an increased likelihood of
depression (OR 1.74, 95% CI 1.12–2.70). There was no signiﬁcant
association between the ﬁrst birth age groups. There was no
signiﬁcant association between depression onset and increased
duration of breastfeeding.
3.3. Exogenous hormone-related factors
Compared to the group who had never used oral contraceptives
in their lifetime, women who continued their oral contraceptive
use for 23 months or longer had an odds ratio of 1.55 (95% CI:
0.94–2.55). If women began using HRT at 48 years old or younger,
the odds ratio increased to 3.86 (95% CI: 2.10–7.09) compared to
the women who had never used HRT (data not shown). Likewise,
as the duration of HRT increased, the odds ratio increased
(P-trend, o0.001). In particular, if the duration of HRT was longer
than 8 months, the odds ratio increased with statistical signiﬁ-
cance (for an HRT duration of 8–35 months, OR¼2.89, 95% CI:
1.54–5.44; for an HRT duration Z36 months, OR¼2.37, 95% CI:
1.38–4.08).
4. Discussion
In this study, an earlier menopause age was associated with
post-menopausal onset depression. For exogenous hormone-
related factors, longer oral contraceptive and hormone replace-
ment therapy usage were associated with an increased risk for
depression. In particular, for those who used hormone replace-
ment therapy, those who started using HRT at a younger age had
the highest risk for depression. Despite that depression has
multiple etiologies in its disease onset, this study suggests the
obvious associations between several factors related to the female
hormonal system and post-menopausal onset depression.
In our study, mean reported age of menarche was 16 years, and
this age is older than what is reported in the current Caucasian
population. However, the age at menarche in our study is con-
sistent with a previous report that showed that approximately
56.5% of women who were born between 1940 and 1949 had
menarche at 15–16 years (Park et al., 2006).
In this study, there was a signiﬁcant trend between a longer
period of reproductive years and a reduced risk of depression
onset. Menopausal age, but not menarche age, was the major
determinant in this relationship. This result is very similar to a
study conducted in the European population (Ryan et al., 2008).
There are few studies that have focused on the effects of repro-
ductive factors on depression onset, and one study asserted that
early menopause increases the risk of depression (Harlow et al.,
2003). Because the age of menarche has a narrower distribution
range compared to the age of menopause, the protective effect
seems to have been masked. Some studies have indicated that
women are more susceptible to depression if they start menstrua-
tion at a younger age (Harlow et al., 2004), but our ﬁndings were
not statistically signiﬁcant.
In this study, the mean age of depression diagnosis was
approximately 58.7 years. Several studies have reported that the
age of menopause alters the risk of diseases, such as ischemic
stroke and breast cancer, after age 60 (Lisabeth et al., 2009; Shin
et al., 2011). Late menopause extends reproductive years and
lengthens lifetime estrogen exposure, which increases the risk of
hormone-related diseases. It is known that early menopause is
associated with adverse socio-economic factors, such as manual
working class (Parazzini and Progetto Menopausa Italia Study
Group, 2007) or low educational level (Lawlor et al., 2003) which
can also affect the onset of depression. However, we controlled for
these factors in the ﬁnal adjusted model.
Menopause that occurs by artiﬁcial factors, such as surgery,
exhibits a signiﬁcantly increased odds ratio of approximately 80%
compared to natural menopause. This ﬁnding supports previous
studies that have suggested that menopause provoked by other
artiﬁcial causes results in rapid changes in the hormonal system,
which encompasses more severe depressive symptoms (Unsal
et al., 2011). In addition to biological explanations limited to
hormonal effects, some argue that this phenomenon can be based
on complications of surgery, body image alteration, inability to
reproduce, and negative effects on sexual life and pain (Azadeh-
Ghamsari et al., 2002; Vrzackova et al., 2010).
Although we demonstrated a marginal signiﬁcance, our results
regarding the number of pregnancies is not consistent with the
results from a previous study (Vesga-Lopez et al., 2008) that
showed a decreased risk of mood disorders among pregnant
women compared to non-pregnant women. However, more recent
meta-analysis and systematic reviews (Bennett et al., 2004; Ross
and McLean, 2006) report heterogeneity in results regarding the
association between number of pregnancies and depression. There
are several studies showing no typical harmful effect of pregnancy
to women's mental health similar to this study. One longitudinal
study conducted in Australia showed that there was no association
between pregnancy and increased symptoms of depression (Leach
et al., 2014). Another prospective cohort study showed no altera-
tion in psychological distress during the time of pregnancy (van
Bussel et al., 2006). One study conducted within twins identiﬁed
no biological associations between increased parity and the risk of
psychiatric illnesses, and it suggested that social factors are a
major determinant in the higher prevalence of psychiatric disea-
ses in married women (Dean and White, 1996). Another study
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Table 2
Odds ratios for the association between each reproductive factors and 276 post-menopausal onset depression of menopaused women in South Korea NHANES 2010–2012.
(weighted).
Variables Depression () Depression (þ) Odds ratioa (95% CI) Odds ratiob (95% CI) Odds ratioc (95% CI)
Endogenous hormonal factors
Menstruation duration
o30 years 1016 81 1.00 (ref) 1.00 (ref) 1.00 (ref)
30–33 years 889 56 0.66 (0.41–1.05) 0.66 (0.41–1.05) 0.66 (0.41–1.05)
34–35 years 1158 68 0.61 (0.40–0.95) 0.58 (0.37–0.90) 0.56 (0.36–0.88)
435 years 1530 71 0.44 (0.29–0.67) 0.41 (0.27—0.64) 0.41 (0.27–0.62)
P-trend o0.001 o0.001 o0.001
Menarche age
r14 years 1016 57 1.00 (ref) 1.00 (ref) 1.00 (ref)
15–16 years 1599 102 0.98 (0.65–1.48) 0.98 (0.64–1.49) 0.98 (0.64–1.49)
17 years 850 54 0.83 (0.50–1.36) 0.80 (0.48–1.34) 0.82 (0.49–1.38)
Z18 years 1128 63 0.76 (0.48–1.20) 0.75 (0.48–1.18) 0.77 (0.48–1.21)
P-trend 0.178 0.144 0.183
Menopause age
o46 years 999 78 1.00 (ref) 1.00 (ref) 1.00 (ref)
46–49 years 1156 84 0.82 (0.55–1.21) 0.80 (0.54–1.21) 0.79 (0.53–1.19)
50–51 years 953 47 0.47 (0.30–0.72) 0.44 (0.28–0.69) 0.43 (0.28–0.67)
Z52 years 1485 67 0.39 (0.24–0.61) 0.36 (0.23–0.57) 0.35 (0.22–0.55)
P-trend o0.001 o0.001 o0.001
Type of menopause
Natural 4027 227 1.00 (ref) 1.00 (ref) 1.00 (ref)
Artiﬁcial 566 49 1.79 (1.16–2.75) 1.77 (1.17–2.69) 1.75 (1.16–2.66)
Duration between menarche and ﬁrst pregnancy among ever pregnant women
r4 years 1068 57 1.00 (ref) 1.00 (ref) 1.00 (ref)
5–7 years 1187 88 1.52 (0.96–2.40) 1.51 (0.95–2.41) 1.48 (0.93–2.36)
8–10 years 1135 72 1.24 (0.76–2.04) 1.22 (0.72–2.07) 1.17 (0.68–2.01)
Z11 years 1082 55 1.30 (0.79–2.15) 1.28 (0.75–2.19) 1.21 (0.70–2.10)
P-trend 0.519 0.644 0.810
Total pregnancy (number) including abortion
0–3 1407 64 1.00 (ref) 1.00 (ref) 1.00 (ref)
4 868 56 1.21 (0.71–1.98) 1.22 (0.74–2.01) 1.20 (0.73–1.98)
5–6 1345 85 1.09 (0.73–1.62) 1.11 (0.74–1.68) 1.09 (0.72–1.64)
Z7 973 71 1.25 (0.82–1.90) 1.31 (0.84–2.05) 1.30 (0.84–2.04)
P-trend 0.395 0.302 0.330
Pregnancy (number) without any abortion
0–2 1768 91 1.00 (ref) 1.00 (ref) 1.00 (ref)
3 1085 82 1.10 (0.76–1.59) 1.04 (0.70–1.52) 1.05 (0.71–1.54)
4 733 42 0.79 (0.50–1.24) 0.74 (0.46–1.20) 0.77 (0.47–1.25)
Z5 927 57 0.95 (0.62–1.45) 0.99 (0.55–1.78) 1.05 (0.58–1.89)
P-trend 0.577 0.730 0.888
Total abortion (number) among ever pregnant women
0 1312 51 1.00 (ref) 1.00 (ref) 1.00 (ref)
1 1197 73 1.62 (1.02–2.56) 1.57 (0.98–2.52) 1.66 (0.98–2.51)
2 981 61 1.50 (0.93–2.43) 1.46 (0.90–2.39) 1.44 (0.89–2.36)
Z3 1023 87 1.89 (1.24–2.89) 1.79 (1.15-2.77) 1.74 (1.12–2.70)
P-trend 0.005 0.014 0.021
Spontaneous abortion among ever pregnant women
Never 3464 205 1.00 (ref) 1.00 (ref) 1.00 (ref)
Ever 1049 67 1.12 (0.79–1.60) 1.10 (0.77–1.58) 1.10 (0.77–1.57)
Artiﬁcial abortion among ever pregnant women
Never 1882 89 1.00 (ref) 1.00 (ref) 1.00 (ref)
Ever 2631 183 1.40 (1.03–1.90) 1.35 (0.98–1.87) 1.33 (0.97–1.84)
First birth age among ever parous women
r21 years 1189 61 1.00 (ref) 1.00 (ref) 1.00 (ref)
22–23 years 970 84 1.75 (1.10–2.78) 1.71 (1.05–2.77) 1.68 (1.03–2.75)
24–25 years 1020 59 1.03 (0.63–1.70) 1.01 (0.59–1.73) 0.98 (0.57–1.70)
Z26 years 1293 68 1.10 (0.69–1.76) 1.06 (0.63–1.80) 1.02 (0.60–1.75)
P-trend 0.731 0.604 0.489
Last birth age among ever parous women
r27 years 1126 71 1.00 (ref) 1.00 (ref) 1.00 (ref)
28–30 years 1300 81 1.02 (0.67–1.56) 1.01 (0.67–1.52) 0.99 (0.65–1.50)
31–33 years 923 65 0.92 (0.60–1.40) 0.90 (0.58–1.39) 0.87 (0.56–1.37)
Z34 years 1103 53 0.72 (0.46–1.15) 0.74 (0.44–1.25) 0.74 (0.43–1.26)
P-trend 0.145 0.229 0.232
Breastfeeding duration among ever parous women
0–27 months 856 46 1.00 (ref) 1.00 (ref) 1.00 (ref)
24–41 months 1189 75 0.87 (0.59–1.60) 0.93 (0.57–1.53) 0.95 (0.57–1.58)
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suggested that even pregnancy might affect depression and that
childbirth may prevent harmful effects (Evans et al., 2001). It is
also possible that living with many children might reduce the risk
of depression which might have been affected by the pregnancy
itself, but we were unable to compare the number of living
children with total parity due to a lack of information. Further
research should be conducted to evaluate the true meaning of the
biological effects of parity on the development of depression.
Breastfeeding is well recognized for its beneﬁcial effects on
mothers’ mental health, and several studies report that breast-
feeding mothers have lower susceptibility to depression (Assarian
et al., 2014). Another study suggests that breastfeeding can
increase the negative mood of women (Mezzacappa and Katlin,
2002). Additional researchers suggested that breastfeeding may
provide an anti-depressive effect (Field, 2008). Research has also
proposed that breastfeeding diminishes the hormonal and psy-
chological risk conditions for postpartum depression (Figueiredo
et al., 2013). Other studies claim that breastfeeding weakens the
stress response related to the cortisol pathway, which can protect
against maternal depression (Heinrichs et al., 2002; Tu et al.,
2006). Hormones related to breastfeeding, such as oxytocin and
prolactin, seem to have an anxiolytic or antidepressant effect
(Mezzacappa and Katlin, 2002).
For exogenous hormone-related factors, the results were more
pronounced than those of the endogenous hormone-related fac-
tors. There have previously been many contradictory results
regarding the effects of oral contraceptives. In Finland, the use of
hormonal contraception was not associated with a negative impact
on mental health (Toffol et al., 2012). However, this study was
conducted in a large population and used the Beck Depression
Inventory-13 as a diagnostic tool, which can produce relatively
subjective results. Furthermore, there was no clear association
between the duration of oral contraceptive usage and mental
health effects in this study. Additionally, a recent meta-analysis
states that there are limited data on evaluating hormonal contra-
ception and depression (Bottcher et al., 2012). Contrary to previous
outcomes, which showed a decreased risk of depression as the
duration of oral contraceptive usage increased beyond 10 years
(Ryan et al., 2008), our results show that the odds ratio increases
as the duration of oral contraceptive usage increases. If women
used oral contraceptives for 23 months or longer, the odds ratio of
depression increased by approximately 55%. There are warnings
that the synthetic female sex hormones used in oral contracep-
tives may be associated with the risk of adverse effects on mental
health. In several reports, it has been mentioned that certain
women developed depressive symptoms after they used hormonal
contraceptives (Andersen et al., 2014). Our results support these
previous reports and suggest clear implications of the possible
hazardous impact of oral contraceptives on mental health.
There have been consistent claims of the beneﬁcial effects of HRT
on depressive mood (Whooley et al., 2000). A pilot study was
previously conducted in Korea that also supported the protective
effects of HRTs on depression (Lim et al., 2006). Several articles
proposed the use of estrogen in women with a reproductive depres-
sion disorder (Studd and Panay, 2009). As stated in the previous
study, this study agrees with only a few reports suggesting that the
use of HRTs may increase the risk of depression (Ryan et al., 2008).
Based on our results, the starting age and duration of HRT use seems
to inﬂuence the odds ratios for depression. In particular, if women
started their HRT at 48 years old or younger, the odds ratio was more
than three times greater. Because women tend to begin HRT after
suffering from post-menopausal symptoms, such as hot ﬂashes, the
early use of HRT may reﬂect early menopause. In our data, we
showed a linear correlation between menopause age and the starting
age of HRT in the HRT group (data not shown). Therefore, further
research is needed to evaluate the true factors affecting the onset of
depression. However, it seems evident that the use of HRTs increases
the risk of post-menopausal depression. Additionally, the previous
study conducted in Korea was conducted in only 65 women and
reported a marginal signiﬁcance of a reduced risk of HRTs on
depression (Lim et al., 2006).
This study has various strengths. First, KNHANES is a nationally
representative large survey in Korea, and the questionnaires were
conducted by trained interviewers in a standardized manner. With
the large population used in this study, some results, such as the
increased duration of hormone replacement therapy that was not
statistically signiﬁcant in a previous study (Ryan et al., 2008), had
a signiﬁcant result in this study. Additionally, because the ques-
tionnaires in KNHANES contain a large amount of information, we
were able to access many factors, such as the presence of comorbid
diseases or the education of parents, which were previously
known to be related to depression and were found to be effective
covariates to include in the model.
However, this study was based on a cross-sectional design;
therefore, we could only interpret the results pertaining to certain
temporal relationships based on the time information regarding
menopause and the onset of depression. Additionally, this study is
one of only a few studies that address depression diagnosed by a
Table 2 (continued )
Variables Depression () Depression (þ) Odds ratioa (95% CI) Odds ratiob (95% CI) Odds ratioc (95% CI)
42–77 months 1,057 69 0.88 (0.53–1.46) 0.77 (0.43–1.36) 0.81 (0.44–1.49)
Z78 months 1,045 58 0.91 (0.56–1.48) 0.81 (0.43–1.55) 0.86 (0.44–1.70)
P-trend 0.622 0.445 0.594
Exogenous hormonal factors
Oral contraceptive usage duration (months)
Never 3,605 198 1.00 (ref) 1.00 (ref) 1.00 (ref)
r10 months 326 19 1.23 (0.67–2.26) 1.15 (0.64–2.08) 1.15 (0.63–2.09)
11–22 months 253 22 1.24 (0.70-2.18) 1.15 (0.65–2.03) 1.15 (0.65–2.03)
Z23 months 409 37 1.73 (1.08–2.77) 1.56 (0.95–2.58) 1.55 (0.94–2.55)
P-trend 0.021 0.080 0.088
Hormone replacement therapy duration (months)
Never 3,906 206 1.00 (ref) 1.00 (ref) 1.00 (ref)
r7 months 228 18 1.55 (0.85–2.83) 1.54 (0.82–2.88) 1.55 (0.82–2.94)
8–35 months 190 26 2.89 (1.59–5.27) 2.95 (1.58–5.51) 2.89 (1.54–5.44)
Z36 months 269 26 2.49 (1.44–4.32) 2.45 (1.43–4.21) 2.37 (1.38–4.08)
P-trend o0.001 o0.001 o0.001
a Crude odds ratio.
b Adjusted with age, comorbidity and alcohol use(AUDIT score).
c Adjusted with age, comorbidity, alcohol use(AUDIT score), occupational status and marital status.
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physician in a large population. Several studies have failed to
differentiate between major depressive disorder, according to the
clinical diagnostic criteria such as the Diagnostic and Statistical
Manual of Mental Disorders (DSM) or the International Classiﬁca-
tion of Diseases and Related Health Problems, 10th Revision (ICD-
10), and other symptoms such as simple depressive mood (Bloch
et al., 2000; Figueiredo et al., 2013; Ryan et al., 2008; Unsal et al.,
2011). However, there remains a chance of underestimation if
women answered ‘yes’ to the question: “Have you ever been
diagnosed with depression? If so, when?” This question may be
more accurate in assessing depressive disorder.
5. Limitations
There are several limitations in this study. All data were
collected from interviews using questionnaires and were reviewed
retrospectively. Some inaccuracies may occur, especially because
participants had to remember their entire lifetime of reproductive
events. Retrospective reports of age at menarche are quiet inaccu-
rate, so the validity of certain exposure variables are somewhat
questioned. However, one study conducted in the Korean Multi-
Center Cancer Cohort (KMCC) study showed a strong percent
agreement (69.4%) in age at menarche even if the error range
was set less than 1 year (Ko et al., 2008). Therefore, the reprodu-
cibility of the data according to menarche age is considered to be
acceptable. Likewise, it is possible that women with depression
may tend to answer less accurately. However, the KNHANES
contains many items related to the history of participants, and
there is no particular reason for depressed women to answer more
inaccurately on the questions involved in this study than other
questions because they were not aware of the objective of this
study. Furthermore, all questions were asked by trained inter-
viewers to prevent illogical replies. Therefore, we estimated that
there were no signiﬁcant errors contributing to biased results.
Similarly, because we excluded those women with unknown
menopausal statuses, there may be a potential bias. Because it was
difﬁcult to interpret certain temporalities between hormone-
related factors and depression in the pre-menopause population,
we likely excluded some women who were not menopausal. In
those women with an unknown menopause status, some may
have had depression after menopause, which would have reduced
the overall power of this study.
In the process of building models including possible confounders,
items such as family history of depression or drug use pattern, were
unable to be applied in the ﬁnal model. In KNHANES 2010–2012,
there is no information for family history of depression. Only the
familial history for hypertension, hyperlipidemia, ischemic heart
disease, stroke and diabetes is included. Similarly, only information
on drug prescriptions in the past 2 weeks was available. As it is not
adequate to assume effect of relatively short period of drug prescrip-
tion on depression, which is a chronic state, we did not include this
factor in the ﬁnal model. However, this element might have caused
missed possible effects of these confounders on the associations
between the reproductive factors and depression.
A total of 276 participants (5.1%) were diagnosed with depres-
sion after menopause, which is less than previous reports (6.7%)
(Cho, 2011). Because the participants in KNHANES were limited to
only non-institutionalized people, fewer people with depression
may be included in this study. The results of the present study
might therefore underestimate the true prevalence.
6. Conclusions
In conclusion, in this study of Korean women, hormone-related
factors such as age at menopause and hormone replacement therapy
were associated with post-menopausal onset depression. According to
our results, we suggest that careful psychiatric screening for depres-
sion should be provided to women who undergo early menopause,
menopause by artiﬁcial procedures or have a large number of
pregnancies. Additionally, women who use oral contraceptives or
HRTs for longer than a particular duration or women who start HRT
early should also be carefully observed for depression development.
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